Combined cord blood stem cells and gene therapy enhances angiogenesis and improves cardiac performance in mouse after acute myocardial infarction

European Journal of Clinical Investigation

Volumn 35, Issue 11, 2005, Pages 677-686

  Chen, H K ^a   Hung, H F ^a   Shyu, Kou Gi ^a,b,c   Wang, B W ^a   Sheu, J R ^b,c   Liang, Y J ^a   Chang, C C ^a   Kuan, P ^a  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Acute myocardial infarction; Angiogenesis; Angiopoietin 1; Cell therapy; Vascular endothelial growth factor; Vasculogenesis

Indexed keywords

ANGIOPOIETIN 1; CD34 ANTIGEN; COMPLEMENTARY DNA; PARVOVIRUS VECTOR; VASCULOTROPIN;

ACUTE HEART INFARCTION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY DENSITY; CELL CULTURE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; ECHOCARDIOGRAPHY; GENE THERAPY; GENETIC TRANSDUCTION; HEART INFARCTION SIZE; HEART PERFORMANCE; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCID MOUSE; UMBILICAL CORD; WESTERN BLOTTING;

ANGIOPOIETIN-1; ANIMALS; ANTIGENS, CD34; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; GENE THERAPY; HEART; HUMANS; MALE; MICE; MICE, SCID; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PATHOLOGIC; RNA, MESSENGER; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 27844472770     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2005.01565.x     Document Type: Article

References (35)

1. Nakahata T, Ogawa M. Hemopoietic colony-forming cells in umbilical cord blood with extensive capability to generate mono and multi-potential hemopoietic progenitors. J Clin Invest 1982;70:1324-8.
2. Mayani H, Lansdorp PM. Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood. Blood 1994;83:2410-7.
3. Murohara T, Ikeda H, Duan J, Shintani S, Saaki KI, Eguchi H et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000;105:1527-36.
4. Tanavde VM, Malehorn MT, Lumkul R, Gao Z, Wingard J, Garrett ES et al. Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood. Exp Hematol 2002;30:816-23.
5. Weissman IL. Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science 2000;287:1442-6.
6. Kaji EH, Leiden JM. Gene and stem cell therapies. JAMA 2001;285:545-50.
7. Kallka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000;97:3422-7.
8. Kawamoto A, Gwon HC, Igaguro H, Yamaguchi JI, Uchida S, Masuda H et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischaemia. Circulation 2001;103:634-7.
9. Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002;106:3009-17.
10. Isner JM. Myocardial gene therapy. Nature 2002;415:234-9.
11. Iwaguro H, Yamaguchi JC, Kalka C, Murasawa S, Masuda H, Hayashi SI et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 2002;105:732-8.
12. Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD et al. Leakage-resistant blood vessels in mice transgenetically over-expressing angiopoietin-1. Science 1999;286:2511-4.
13. Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD, Isner JM. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem 1998;273:18514-21.
14. Papaetropoulos A, Garcia-Cardena G, Dengler TJ, Maisonpierre PC, Yancopoulos GD, Sessa WC. Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. Lab Invest 1999;79:213-23.
15. Kim I, Kim HG, Moon SO, Chae SW, So JN, Koh KN et al. Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion. Circ Res 2000;86:952-9.
16. Shyu KG, Manor O, Magner M, Yancopoulos GD, Isner JM. Direct intramuscular injection of plasmid DNA encoding angiopoietin-1, but not angiopoietin-2 gene augments revascularization in rabbit ischaemic hindlimb model. Circulation 1998;98:2081-7.
17. Takahashi K, Ito Y, Morikawa M, Kobune M, Huang J, Tsukamoto M et al. Adenoviral-delivered angiopoietin-1 reduces the infarction size and attenuates the progression of cardiac dysfunction in the rat model of acute myocardial infarction. Mol Ther 2003;8:584-92.
18. Shyu KG, Wang BW, Yang YH, Tsai SC, Lin S, Lee CC. Amphetamine activates connexin 43 gene expression in cultured neonatal rat cardiomyocytes through JNK and AP-1 pathway. Cardiovasc Res 2004;63:98-108.
19. Shyu KG, Wang MT, Wang BW, Chang CC, Leu JG, Kuan P et al. Intramyocardial injection of naked DNA encoding HIF-1α/VP16 hybrid to enhance angiogenesis in an acute myocardial infarction model in the rat. Cardiovasc Res 2002;54:576-83.
20. Zhang S, Wang D, Estrov Z, Ray S, Willerson JT, Yeh ETH. Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes in vivo. Circulation 2004;110:3803-7.
21. Murry CE, Soonpaa MH, Relnecke H, Nakajima H, Nakajima HO, Rubart M et al. Hematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004;428:664-8.
22. Alessandri G, Emanueli C, Madeddu P. Genetically engineered stem cell therapy for tissue regeneration. Ann NY Acad Sci 2004;1015:271-84.
23. Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischaemic disease. Part II: cell-based therapies. Circulation 2004;109:2692-7.
24. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B et al. Bone marrow cells regenerate infracted myocardium. Nature 2001;410:701-5.
25. Strauer BE, Brehm M, Zeus T, Kostering M, Hernandez A, Sorg RV et al. Repair of infracted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002;106:1913-8.
26. Zentillin L, Marcello A, Giacca M. Involvement of cellular double-strand DNA break-binding proteins in processing of recombinant adeno-associated virus (AAV) genome. J Virol 2001;75:12279-87.
27. Siddiqui AJ, Blomberg P, Wardell E, Hellgren I, Eskandarpour M, Islam KB et al. Combination of angiopoietin-1 and vascular endothelial growth factor gene therapy enhances arteriogenesis in the ischaemic myocardium. Biochem Biophy Res Co 2003;310:1002-9.
28. Shyu KG, Chang H, Isner JM. Synergistic effect of angiopoietin-1 and vascular endothelial growth factor on neoangiogenesis in hypercholesterolemic rabbit model with acute hindlimb ischaemia. Life Sci 2003;73:563-79.
29. Kawamoto A, Murayama T, Kusano K, Ii M, Tkebuchava T, Shintani S et al. Synergistic effect of bone marrow mobilization and vascular endothelial growth factor-2 gene therapy in myocardial ischaemia. Circulation 2004;110:1398-405.
30. Duan D, Yue Y, Engelhardt JF. Expanding AAV packaging capacity with trans-splicing or overlapping vectors: a quantitative comparison. Mol Ther 2001;4:383-91.
31. Iwaguro H, Yamaguchi JC, Kalka C, Murasawa S, Masuda H, Hayashi SI et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 2002;105:732-8.
32. Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ, Giordano FJ et al. The VIVA trial: vascular endothelial growth factor in ischaemia for vascular angiogenesis. Circulation 2003;107:1359-65.
33. Rajagopalan S, Mohler ER, Lederman RJ, Mendelsohn FO, Saucedo JF, Goldman CK et al. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 2003;108:1933-8.
34. Rehman J, Li J, Orschell CM, March KL. Peripheral blood 'endothelial progenitor cells' are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003;107:1164-9.
35. + cells. Eur J Hematol 2003;70:143-50.